RECOMBINANT FUSION PROTEINS FOR PREVENTING OR TREATING ADHESIONS OF TISSUES OR ORGANS |
|||||||
| 申请号 | US15506558 | 申请日 | 2015-08-20 | 公开(公告)号 | US20170253864A1 | 公开(公告)日 | 2017-09-07 |
| 申请人 | Akesion GmbH; | 发明人 | Klaus Rübsamen; Stephan Witte; | ||||
| 摘要 | The invention relates to recombinant fusion proteins comprising a fibrinogenolytic enzyme having an amino acid sequence that is C-terminally and/or N-terminally linked to the amino acid sequence of at least one high-molecular inert stabilization domain with a molecular weight of >50 kDa, for the prevention or treatment of adhesions at tissues or organs, in particular peritoneal adhesions following surgical interventions. | ||||||
| 权利要求 | |||||||
| 说明书全文 | |||||||
QQ群二维码
意见反馈
意见反馈